Edit

Qiming Venture Partners

http://www.qimingvc.com/
Last activity: 08.06.2025
Active
Categories: ExchangeFinTechFirmGrowthHealthTechInvestmentManagementMarketMedtechReputation
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.

Currently Qiming Venture Partners manages nine US Dollar funds and six RMB funds with $5.9 billion in assets under management. Since our establishment, we have invested in outstanding companies in the TMT and healthcare industries at the early and growth stages.

Since our debut, we have backed over 380 fast-growing and innovative companies. Over 130 companies are already listed on NYSE, NASDAQ, HKEx, Gretai Securities Market, Shanghai Stock Exchange and Shenzhen Stock Exchange, or achieved exit through M&A and other means. There are also over 40 portfolio companies that have achieved unicorn status.

Many of our portfolio companies are today's most influential firms in their respective sectors, including Xiaomi (SEHK:1810), Meituan (SEHK:3690), Bilibili (NASDAQ:BILI, SEHK:9626), Roborock (SHSE:688169), Gan & Lee Pharmaceuticals (SHSE: 603087), Tigermed (SZSE:300347, SEHK:3347), Zai Lab (NASDAQ:ZLAB, SEHK:9688), Venus MedTech (SEHK:2500), CanSino Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT Medical (SHSE:688617), Sanyou Medical (SHSE:688085), New Horizon Health (SEHK:6606), AmoyDx (SZSE:300685), Berry Genomics (SZSE:000710), SinocellTech (SHSE: 688520), WeDoctor Group, and UBTech among many others.
Followers
7.03K
Website visits
8.4K /mo.
Mentions
114
Location: China, Shanghai
Employees: 51-200
Founded date: 2006

Mentions in press and media 114

DateTitleDescription
08.06.2025GenEditBio and Newborn Town: Pioneering Innovations in Hong Kong's Biotechnology and Entertainment SectorsIn the bustling heart of Hong Kong, two companies are making waves in their respective fields. GenEditBio, a biotechnology start-up, is pushing the boundaries of genetic medicine. Meanwhile, Newborn Town, a social entertainment giant, is re...
06.06.2025GenEditBio Announces First Patient Dosed in Investigator-Initiated Trial of GEB‑101, World's First In Vivo CRISPR-Cas Ribonucleoprotein-Based Genome Editing Investigational Therapy for TGFBI Corneal D...HONG KONG, BEIJING and BOSTON, June 6, 2025 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology start-up company focusing on genome editing therapeutic solutions through the discovery of novel and pre...
05.06.2025LP behind 'China's Silicon Valley' to back funds of Qiming, Monolith, othersZhongguancun Science City (ZGC Science City), a local government investment firm in Beijing, will invest in funds managed by Qiming Venture Partners, Monolith Management, and Meituan’s DragonBall Capital, among two others, amid the growing ...
09.05.2025The AIoT Revolution: Terminus Group and the Future of Smart ConnectivityThe world is on the brink of a technological renaissance. By 2025, over 30 billion devices will be connected globally. This surge is not just a number; it’s a revolution. At the heart of this transformation lies AIoT—Artificial Intelligence...
07.05.2025Budget brand no more? Pelliot readies Hong Kong IPO after profit surgePelliot first signaled its IPO ambitions in August 2023, when it filed for listing guidance with the Anhui arm of the China Securities Regulatory Commission. The goal was a debut on the Shenzhen Stock Exchange. But by April 2025, the compan...
05.05.2025China’s PE-VC market braces for shakeup as tough times weed out trailing GPsThe ongoing reshuffle in Greater China’s private investment market is expected to intensify as significant macro challenges eliminate trailing managers with unwanted “zombie funds”.
04.04.2025Streaming Giants and Storytelling Startups: A Tale of Triumph and Transition in India’s Digital LandscapeIn the vast digital landscape of India, two narratives unfold: the roaring success of Amazon MX Player’s “Aashram” and the turbulent journey of Pratilipi, a digital storytelling platform. Both stories reflect the changing tides of entertain...
04.04.2025Digital storytelling platform Pratilipi Raises USD 20 Mn in Series E round led by Jungle Ventures The Gurugram-based firm plans to utilise the funds to diversify into new storytelling formats such as ...Digital storytelling platform Pratilipi has raised USD 20 million in its Series E round, led by Jungle Ventures. The round includes USD 12 million in primary capital from two individual investors and USD 8 million via secondary share sales....
03.04.2025Jungle Ventures leads Series E funding in Pratilipi as Chinese VCs exit, valuation dropsRanjeet Pratap Singh, co-founder and CEO, Pratilipi Singapore-based venture capital firm Jungle Ventures has led a Series E funding round of $20 million (about Rs 171 crore) in digital storytelling platform Pratilipi. The round includes $12...
01.04.2025Aramco's Prosperity7 leads $73m financing in China's Spirit AIProsperity7 Ventures, a venture capital (VC) fund of Saudi oil giant Aramco, has led a Series Pre-A funding round of 528 million yuan ($72.8 million) in China’s Spirit AI amid a frenzy of early-stage financing in embodied intelligence. Spir...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In